Table of Contents
Welcome. I’m Dr. Jimenez, and I’m honored to share with you some of the most compelling and current insights into the complex world of metabolic health. As a Doctor of Chiropractic (DC) and a Family Nurse Practitioner-Advanced Practice Registered Nurse (FNP-APRN), I have dedicated my career to integrating diverse fields of medicine to create a more holistic and effective model of patient care. Today, I want to move beyond surface-level statistics about our global health crisis and delve into the intricate physiological mechanisms that underlie conditions such as insulin resistance, obesity, and type 2 diabetes. This isn’t just about numbers on a scale or a blood sugar reading; it’s about understanding the profound, interconnected systems within our bodies that govern our health, energy, and longevity.
In this educational post, we will embark on a deep dive into the latest findings from leading researchers, exploring how modern, evidence-based methods are reshaping our understanding of metabolic dysfunction. We will begin by confronting the pervasive issue of hidden sugars in our “healthy” food supply and how they contribute to inefficient energy utilization. From there, we’ll explore the critical, yet often overlooked, role of the sympathetic nervous system and chronic stress. You’ll learn how elevated cortisol directly sabotages insulin regulation, keeping your body in a perpetual “fight or flight” state that hoards glucose and fuels inflammation. We will then pivot to the cellular level to uncover the molecular machinery of insulin signaling. I’ll explain the indispensable role of micronutrients like chromium and how its deficiency, widespread in our modern diet, can impair insulin receptor function, effectively locking the door to glucose entry into our cells.
Furthermore, we will unravel the concept of meta-inflammation—a chronic, low-grade inflammatory state driven by metabolic dysregulation. I’ll show you how to identify subtle clues of this inflammation, such as elevated basophils on a standard blood panel, and connect them to key inflammatory cytokines like Interleukin-6 (IL-6). We’ll discuss the Warburg effect, a metabolic shift once thought to be exclusive to cancer cells, and how its principles of inefficient energy production are alarmingly relevant to anyone with pre-diabetes. A significant portion of our discussion will focus on the gut-muscle axis. We’ll examine groundbreaking research on how an imbalanced microbiome releases endotoxins, such as lipopolysaccharide (LPS), which breach the gut barrier, enter circulation, and trigger systemic inflammation and insulin resistance. Finally, we will tie all these concepts together, emphasizing that lean muscle mass is the ultimate currency of metabolic health and exploring how we can use this knowledge to create sustainable, personalized strategies for our patients. This is about empowering you with a deeper understanding, moving beyond simplistic advice to grasp the “why” behind the protocols, and ultimately fostering true, lasting health.
I’ve presented the staggering statistics on metabolic disease many times, and I won’t belabor them again. We all know we have a massive problem on our hands. But if you take a moment to look closely at what’s on our store shelves, you’ll begin to understand why. I recently saw a product that perfectly encapsulates the issue: a “healthy” green tea soda. The label proudly boasted that it was organic and gluten-free. It sounds virtuous, doesn’t it? But when you look at the nutrition facts, you discover it contains the equivalent of 10 teaspoons of sugar. It may be organic sugar, but to your pancreas and your cells, it’s still a massive metabolic burden.
This is a pervasive trend. It’s astonishing to me how many so-called “green drinks” or “health beverages” are loaded with sugar. The manufacturers are trying to make these products palatable to a population whose taste buds have been conditioned to expect intense sweetness. They haven’t learned to appreciate the natural flavors of vegetables or the simple, refreshing taste of water with a squeeze of lemon. Instead, they create concoctions with astronomical levels of sugar. The most egregious example I’ve ever encountered was a beverage containing 88 grams of sugar per serving. To put that into perspective, that is the metabolic equivalent of drinking nearly three cans of Coca-Cola. With products like these masquerading as health food, it’s no wonder that our population is struggling. This is a big, big problem. We’ve seen the data from the COVID-19 era, where up to 80% of hospitalized individuals had pre-diabetes or developed full-blown diabetes. The primary comorbidity? Being overweight.
So, why is excess weight such a critical factor? At its core, almost all chronic metabolic disease stems from inefficient energy utilization. When your body’s intricate system of insulin regulation is thrown off, you lose the ability to process and use fuel efficiently. A primary culprit in this sabotage is a hormone we’re all familiar with: cortisol.
When you are under chronic stress, your body is in a perpetual state of “fight or flight,” a physiological response governed by the sympathetic nervous system. In an acute survival situation—say, a tiger is chasing you—this response is life-saving. Your brain, sensing the danger, commands the release of cortisol. Cortisol’s job is to ensure you have enough fuel for the fight. It does this by altering insulin regulation to keep glucose circulating in the bloodstream, readily available for your muscles and brain. It effectively tells your cells, “Don’t store this glucose right now; we need it for immediate action!”
The problem is that in our modern world, the “tiger” is no longer a predator. It’s the next 50 emails in your inbox, the looming project deadline, the traffic jam, or the constant barrage of negative news. Your body, however, doesn’t differentiate between these stressors. The physiological response is the same. Your brain perceives this chronic, low-grade stress as a constant threat, keeping cortisol levels elevated. This chronically elevated cortisol continuously interferes with insulin’s ability to do its job, leading to what we call insulin resistance. Your body is trying to save you from a threat that requires a physical fight or flight, but instead, you’re sitting at a desk, marinating in a sea of glucose that has nowhere to go.
This is why monitoring markers of sympathetic dominance is so crucial. When I work with individuals, I’m not just looking at their diet. I’m looking at their heart rate variability (HRV), their blood pressure patterns, and their sleep quality. As you wind down for the evening, your heart rate and blood pressure should decrease as your body shifts into a parasympathetic (“rest and digest”) state. Your cortisol levels should be dropping off. If they aren’t, it’s a clear sign of sympathetic dominance. This is why practices like deep breathing are not just “fluffy” wellness tips; they are powerful physiological interventions. Taking just three minutes, three times a day, to practice a simple box breathing technique can activate the vagus nerve and shift your nervous system towards a parasympathetic state. If you are not addressing sympathetic dominance, you will never successfully pull someone out of a chronic inflammatory syndrome. The parasympathetic tone, driven by the neurotransmitter acetylcholine, generates anti-inflammatory signals in the body and brain. This is also why nutrients like phospholipids (such as phosphatidylcholine) are so important, as they are precursors to acetylcholine.
As we’ve established, adipokines—the signaling molecules released from fat cells—are key triggers of this inflammatory cascade. But let’s zoom in even further, to where the rubber meets the road: the insulin receptor on the surface of your cells.
Think of the insulin receptor as a locked door. Glucose is on the outside, wanting to get in to be used for energy. Insulin is the key, but it can’t turn the lock on its own. It needs help. This is where a fascinating molecule called chromodulin comes into play. Chromodulin is an oligopeptide that binds to insulin receptors and potentiates their activity by a factor of 10. To build this vital chromodulin molecule, your body requires four atoms of the mineral chromium.
I like to use the analogy of a delivery truck. Imagine the insulin receptor is a loading dock, and the truck needs to back in to deliver its cargo (glucose). The truck has four wheels, each representing one of the four chromium atoms required to form chromodulin. If I remove two of those wheels, can the truck still dock properly? No. It becomes unstable and ineffective. This is precisely what happens with chromium deficiency.
Our modern food processing methods are a major cause of this deficiency. As we hyper-polish and refine grains, we strip away the bran and germ, where most of the minerals, including chromium, are stored. The result is a very fine, powdery flour that lacks this essential micronutrient. For years, people were told to avoid fats and eat more “healthy” whole grains, but they were often consuming highly processed versions that were metabolically crippling.
When you’re chromium-deficient, your insulin receptors become less sensitive. Your pancreas has to pump out more and more insulin to try to force the message through. This is a classic hallmark of insulin resistance. I’ve seen this play out countless times in my practice. A patient presents with chromium-induced weight gain and insulin resistance. We begin a protocol to replete their chromium stores. Over time, their insulin signaling normalizes, their weight stabilizes, and they feel better. Then, they stop taking the chromium, thinking the problem is “fixed.” Inevitably, the symptoms return. Why? Because they haven’t fixed the underlying dietary pattern that led to the deficiency in the first place. They refilled the reservoir, allowing cellular signaling to resume temporarily. Once that reservoir was depleted again, the dysfunction returned.
This is why chromium supplementation can be a game-changer. The work of pioneering researchers like Dr. Bruce Ames highlighted the importance of chromium. I had conversations with him where he expressed frustration with the standard recommendations. The conventional advice was often 200 micrograms per day, but he argued that this was woefully inadequate for many people, especially those who are already insulin resistant. He suggested that some individuals might need as much as 800 micrograms a day.
Based on this and my clinical experience, I often use a loading dose. I might start a patient on 1,500 micrograms a day for 30 days to quickly get them over that deep trough of deficiency. After that initial period, we can taper down to a maintenance dose of around 800 micrograms. The results can be astounding. Even before the advent of GLP-1 agonist medications, I saw incredible transformations. People’s need for exogenous insulin would decrease dramatically, or in some cases be eliminated. Even for a Type 1 diabetic who doesn’t produce their own insulin, making their cells more sensitive means the insulin they inject works far more effectively. When you fail to address this receptor sensitivity, their insulin needs keep climbing, and the vicious cycle continues. So, my first clinical pearl for you is this: if you are dealing with any form of metabolic syndrome or insulin resistance, you must assess and address chromium status.
Now, let’s connect this back to inflammation. I mentioned earlier that elevated cortisol alters insulin regulation. But what are the other key players? The two major inflammatory cytokines that drive insulin resistance are **Interleukin-6 (IL-6)**and Tumor Necrosis Factor-alpha (TNF-α). These, combined with the hormone cortisol, form a powerful triad that disrupts metabolic function.
How can we see this on a standard blood test without ordering expensive, specialized cytokine panels? There’s a simple, yet incredibly insightful marker on a complete blood count (CBC) with differential: the basophil count. In my clinical experience, a basophil count greater than one is a strong indicator of upregulated IL-6. When you see a basophil count of 1, or especially two or more (which is often flagged as out of range), you can be almost certain that the patient is dealing with IL-6-driven inflammation. I would say that 99% of the time, the insulin-resistant patients I see with an inflammatory component have a basophil count of one or higher. It’s a remarkably consistent correlation.
When this entire system is working well—when insulin binds effectively, the door opens, and glucose enters the cell—it is shuttled to the mitochondria. You pump out abundant amounts of ATP, the energy currency of the cell. This happens via a glucose transporter called GLUT4, which is the primary insulin-sensitive transporter in muscle and fat cells.
However, when the GLUT4 pathway no longer works efficiently due to insulin resistance, the cell shifts to a backup plan. It begins to rely more heavily on GLUT1 transporters. GLUT1 transporters are not dependent on insulin; they are always present on the cell surface and provide a basal level of glucose uptake. This shift is a key feature of the Warburg Effect.
The Warburg Effect, first described by Otto Warburg in the 1920s, is a metabolic phenomenon observed in cancer cells. These cells, even in the presence of ample oxygen, shift their energy metabolism from the highly efficient mitochondrial oxidative phosphorylation to the much less efficient cytoplasmic aerobic glycolysis. This is a passive energy “suck.” The cell loses its ability to regulate glucose uptake and dramatically increases its consumption.
Why is this relevant to insulin resistance? Because the same metabolic shift occurs. When GLUT4 is dysfunctional, cells upregulate GLUT1. A cancer cell, for example, can have a glucose uptake rate that is 50 times greater than a normal, healthy cell. This is the very principle behind a PET scan. The patient is injected with a radio-labeled glucose analog, and the scanner looks for “hot spots” in the body where cells are voraciously sucking up this glucose. Those hot spots are often tumors.
This metabolic shift has profound downstream consequences. The massive increase in glycolysis leads to a buildup of its byproduct, lactate. The cell has to get rid of this acidic waste, so it pumps it out into the surrounding environment. This extracellular lactate creates an acidic microenvironment that triggers angiogenesis(the formation of new blood vessels to feed the hungry cells) and promotes an invasive, metastatic phenotype. It makes a “slime” of connective tissue that allows the dysfunctional cells to thrive and spread.
This is a sobering thought: every patient who walks into your office with a fasting blood sugar of 95 and is carrying an extra 30 pounds is, metabolically speaking, a prime candidate for cancer. I’m not trying to be harsh or alarmist, but we must recognize the gravity of this metabolic state. How many of us have watched a family member or friend go through the ordeal of cancer treatment? It’s a devastating process. Understanding that the seeds of this disease are often sown decades earlier in the soil of insulin resistance should galvanize us to act.
The role of insulin is multifaceted. In a healthy state, it promotes glucose uptake into muscle cells for immediate use or for storage as glycogen. It helps drive **branched-chain amino acids (BCAAs)**into the muscle, promoting tissue repair and anabolism (growth). It also signals the liver to store glucose as glycogen. However, in a state of insulin resistance, the liver starts converting that excess glucose into triglycerides, leading to non-alcoholic fatty liver disease (NAFLD).
The data supporting the long-term dangers of insulin resistance is overwhelming. A landmark 10-year study published in the American Journal of Medicine in 2008 followed 46,578 individuals. The findings were stunning. The study revealed that endothelial dysfunction—the damage to the inner lining of our blood vessels that initiates atherosclerosis—begins to occur when fasting glucose levels are in the 90s. Not 126, the official diagnostic criterion for diabetes, but the 90s. This means that the disease process of insulin resistance, which ultimately leads to type 2 diabetes and heart disease, is well underway for years, even decades, before it is typically “detected” by conventional standards.
But I would argue it’s not that it’s undetectable; it’s that we aren’t using the right lens. We need to practice trend analysis. We must become detectives, compiling different clues from the patient’s physiology. Their fasting glucose is 95. Okay, what else is happening? As a person becomes more insulin resistant, what happens to their electrolyte balance? They begin to lose potassium and magnesium while simultaneously retaining sodium. This is a classic pattern. When you start to thread these pearls of information together, a clear picture of early metabolic dysfunction emerges. We need to intervene here, not wait for the full-blown disease to manifest.
More recent data continues to reinforce this. A 2022 Japanese study of over 37,000 people came to the same conclusions. The emperor has no clothes. The data is out there, but the story is not being told effectively. We are failing to explain to people why they need to lose weight. It’s not just about vanity or fitting into a dress they wore when they were 16. While those can be powerful motivators, the real reason is to reverse the underlying physiological damage.
One of the most exciting and rapidly evolving areas of research is the connection between the gut microbiome and metabolic disease. For years, the top diabetes journals have been publishing studies on this. What happens in the gut does not stay in the gut.
A key finding is the role of lipopolysaccharide (LPS). LPS is a component of the outer membrane of gram-negative bacteria. When your microbiome is out of balance (a condition called dysbiosis), you may experience an overgrowth of these bacteria. LPS is a potent endotoxin. If your gut lining is compromised—a condition commonly known as “leaky gut” or increased intestinal permeability—this LPS can “leak” from the intestines into your bloodstream.
Once in circulation, LPS triggers a massive inflammatory response. It is a powerful activator of the same inflammatory pathways involving TNF-α and IL-6 that we discussed earlier. This systemic inflammation, originating in the gut, is a primary driver of insulin resistance throughout the body. A 2011 study in Diabetes Care examined 537 individuals with type 2 diabetes and found that low serum endotoxin levels were associated with better outcomes, while high endotoxin scores correlated with poor glycemic control, elevated CRP (a marker of inflammation), elevated cholesterol and triglycerides, and low HDL. In essence, people with diabetes have poor microcirculation, which starves the gut lining of oxygen and nutrients, leading to dysbiosis and a leaky gut, which releases LPS, which drives the very inflammation that worsens their diabetes. It’s a vicious cycle.
For the last 20 years, every major diabetes journal has published research on serum lipopolysaccharide. Yet, clinically, it’s been a challenge. There are antibody tests for LPS, but that’s not the same as measuring LPS directly in serum, which is what the research is based on. I’ve been trying to get labs to offer a direct serum LPS test because it’s such a critical piece of the puzzle.
What causes this leaky gut in the first place? Besides infections, the biggest culprit is inflammation itself. As I mentioned, upregulated IL-6 triggers a cascade in the gut epithelial cells that leads to breakdown of tight junctions—the protein structures that seal the space between cells. Furthermore, if you lack a healthy microbiome, you aren’t producing enough butyrate. This short-chain fatty acid is the primary fuel for colon cells and is essential for maintaining a healthy mucosal barrier. Without adequate butyrate and other key nutrients, such as glutamine (which becomes conditionally necessary in these inflammatory states), the villi of the small intestine can become flattened and atrophied, further compromising nutrient absorption and barrier function.
Here’s a simple clinical tool I use to assess for this. I have new patients weigh themselves in the morning after waking and again at night before bed for three consecutive days. If they gain more than 4 pounds from morning to night, it’s a strong indicator of fluid retention due to food sensitivities and gut-derived inflammation. You’ve all heard this from patients: “I was so good for three days, I lost five pounds, and then I had one ‘bad’ meal, and I gained eight pounds back overnight!” They didn’t gain eight pounds of fat. They gained eight pounds of water because their body mounted a massive inflammatory response to foods they had become sensitized to. This simple morning-to-night weight check is a powerful, easy way to screen for significant gut inflammation.
This brings us to the ultimate protector of metabolic health: lean muscle mass. Muscle is the largest site of glucose disposal in the body. It is your metabolic currency. When you have healthy, insulin-sensitive muscle tissue, you have a large “sink” to soak up glucose from your bloodstream, keeping your blood sugar stable.
However, in a state of chronic inflammation and insulin resistance, a process of muscle atrophy is initiated. A key transcription factor involved in this is FOXO1. When FOXO1 is activated in skeletal muscle, it turns on a genetic program that leads to muscle breakdown. This is a devastating consequence of metabolic syndrome. In fact, 60% of skeletal muscle gene expression can be altered in insulin resistance, leading to sarcopenia (age-related muscle loss) and frailty.
This is where some of the newer therapies, when used correctly, can be interesting. For example, GLP-1 agonists have been shown to reverse this FOXO1-mediated muscle atrophy. However, this comes with a critical caveat: you must consume adequate protein and engage in resistance exercise. If you use these medications simply as an appetite suppressant and don’t eat enough, you will experience significant muscle loss, just as you would on any very-low-calorie liquid diet. Human studies show that when combined with proper nutrition and exercise, GLP-1 agonists can reverse muscle atrophy and improve body composition. This underscores the principle that you cannot drug your way out of a problem that was created by lifestyle. The tools must be used to support, not replace, the foundational pillars of health.
Ultimately, all this knowledge is useless if we cannot help our patients implement lasting change. In my experience, there are two main types of people when it comes to health interventions.
First, there are the Spartans. I’m a Spartan. If I come to you for help and you tell me there are three things I need to do, my immediate response will be, “Only three? Why not ten? Give me everything I need to do to fix this now, and I will do it.” Spartans are all-in and thrive on a comprehensive, aggressive plan.
But not everyone is a Spartan, and we must honor that. The second type of person needs a more strategic, gradual approach. They can be overwhelmed by too many changes at once. For these individuals, the key is to identify the highest-leverage behaviors. I often have them do a simple exercise: write down three to five behaviors that are holding them back from their best health. Then, we work together to create one or two meaningful, achievable goals to change those specific behaviors. It’s about building momentum. I had a colleague who would tell potential clients, “Here are five things you need to start doing. When you’ve successfully integrated those, come back, and we’ll work on the next level.” It’s about addressing the behavioral patterns that underpin the physiology.
We have to guide people. We can’t take an absolutist approach and say, “You can never have a piece of cake again!” That creates a mindset of deprivation and failure. The goal is to find that sweet spot—that place where your lab markers are normal, you feel fantastic, you look great, but you can still enjoy life and have a little fun. What if you’re 10 pounds heavier than your “ideal” weight, but you can sustain that lifestyle happily, and all your metabolic markers are perfect? That is a victory. Sustainability is the key.
The single biggest event that creates heart disease is not just high cholesterol; it is the post-prandial spikes in glucose and the subsequent surges of insulin. It is the glucose oscillation—the constant up-and-down—that damages the endothelium. This is why tools like Continuous Glucose Monitors (CGMs) can be so valuable, not as a permanent fixture, but as a 30-day educational tool. It allows people to see in real-time how a specific meal, a poor night’s sleep, or a stressful day affects their blood sugar. It connects their actions to a physiological consequence, which is a powerful catalyst for change. I view the CGM as a lifestyle monitor. For precise diagnostic measurements, finger sticks are still more accurate, but for learning and behavior modification, the CGM is an incredible biofeedback device.
By understanding these intricate connections—between stress and cortisol, chromium and the insulin receptor, the gut and systemic inflammation, muscle mass and glucose disposal—we can move beyond a simplistic “eat less, move more” paradigm. We can become true metabolic detectives, empowering our patients with the knowledge and strategies they need to reclaim their health and build a resilient, vibrant future.
This educational post provides a comprehensive, first-person exploration of the physiological underpinnings of metabolic dysfunction, presented by Dr. Jimenez, DC, FNP-APRN. The discussion moves beyond surface-level statistics to offer a deep dive into the interconnected mechanisms driving insulin resistance, obesity, and type 2 diabetes. The post begins by highlighting the role of chronic stress and elevated cortisolin sabotaging insulin regulation through sympathetic nervous system dominance. It then details the critical, yet often overlooked, role of the micronutrient chromium in activating insulin receptors via the chromodulin molecule, explaining how modern food processing contributes to widespread deficiency.
A central theme is the concept of meta-inflammation, a chronic, low-grade inflammatory state. The post explains how to identify this using common blood markers, such as basophils, which correlate with the inflammatory cytokine IL-6. The discussion bridges this to the Warburg effect, showing how metabolically unhealthy cells adopt inefficient, glucose-guzzling pathways similar to those of cancer cells. A significant focus is placed on the gut-muscle axis, detailing how gut dysbiosis leads to increased intestinal permeability (“leaky gut”), allowing endotoxins such as lipopolysaccharide (LPS) to enter the circulation and drive systemic inflammation and insulin resistance. Finally, the post emphasizes that lean muscle mass is the primary currency of metabolic health and discusses strategies for sustainable lifestyle and behavioral change, including the use of tools like Continuous Glucose Monitors (CGM) for biofeedback and education.
The modern epidemic of metabolic disease is not a simple problem of willpower but a complex physiological breakdown driven by a confluence of factors, including chronic stress, nutrient deficiencies, systemic inflammation, and gut dysbiosis. A reductionist approach that focuses on a single marker, like fasting glucose, is insufficient and often fails to detect disease until significant damage has already occurred. True prevention and reversal require a holistic, systems-based approach. By understanding the intricate web connecting the nervous, endocrine, and immune systems with the microbiome, we can develop far more effective and personalized interventions. Addressing sympathetic dominance, replenishing key micronutrients like chromium, quenching inflammation, healing the gut barrier, and prioritizing the preservation of lean muscle mass are the foundational pillars of restoring metabolic health. The ultimate goal is to move beyond simply managing disease and empower individuals with the knowledge and tools to create sustainable, resilient health that allows them not only to live longer but to thrive.
Insulin Resistance, Metabolic Syndrome, Meta-inflammation, Cortisol, Sympathetic Dominance, Chromium, Chromodulin, Basophils, Interleukin-6 (IL-6), Gut-Muscle Axis, Lipopolysaccharide (LPS), Leaky Gut, Microbiome, Warburg Effect, Lean Muscle Mass, Continuous Glucose Monitor (CGM), Post-prandial Glucose, FOXO1, Functional Medicine, Dr. Jimenez.
Disclaimer: The information contained in this post is for educational and informational purposes only and is not intended as health or medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before undertaking any new health regimen. Never disregard professional medical advice or delay in seeking it because of something you have read on this web page. All individuals must obtain recommendations for their personal situations from their own medical providers.
General Disclaimer, Licenses and Board Certifications *
Professional Scope of Practice *
The information herein on "Metabolic Health & The Gut-Muscle Axis: What You Need To Know" is not intended to replace a one-on-one relationship with a qualified health care professional or licensed physician and is not medical advice. We encourage you to make healthcare decisions based on your research and partnership with a qualified healthcare professional.
Blog Information & Scope Discussions
Welcome to El Paso's Premier Wellness and Injury Care Clinic & Wellness Blog, where Dr. Alex Jimenez, DC, FNP-C, a Multi-State board-certified Family Practice Nurse Practitioner (FNP-BC) and Chiropractor (DC), presents insights on how our multidisciplinary team is dedicated to holistic healing and personalized care. Our practice aligns with evidence-based treatment protocols inspired by integrative medicine principles, similar to those on this site and on our family practice-based chiromed.com site, focusing on naturally restoring health for patients of all ages.
Our areas of multidisciplinary practice include Wellness & Nutrition, Chronic Pain, Personal Injury, Auto Accident Care, Work Injuries, Back Injury, Low Back Pain, Neck Pain, Migraine Headaches, Sports Injuries, Severe Sciatica, Scoliosis, Complex Herniated Discs, Fibromyalgia, Chronic Pain, Complex Injuries, Stress Management, Functional Medicine Treatments, and in-scope care protocols.
Our information scope is multidisciplinary, focusing on musculoskeletal and physical medicine; wellness; contributing etiological viscerosomatic disturbances within clinical presentations; associated somato-visceral reflex clinical dynamics; subluxation complexes; sensitive health issues; and functional medicine articles, topics, and discussions.
We provide and present clinical collaboration with specialists from various disciplines. Each specialist is governed by their professional scope of practice and licensure jurisdiction. We use functional health & wellness protocols to treat and support care for musculoskeletal injuries or disorders.
Our videos, posts, topics, and insights address clinical matters and issues that directly or indirectly relate to our clinical scope of practice.
Our office has made a reasonable effort to provide supportive citations and has identified relevant research studies that support our posts. We provide copies of supporting research studies upon request to regulatory boards and the public.
We understand that we cover matters that require an additional explanation of how they may assist in a particular care plan or treatment protocol; therefore, to discuss the subject matter above further, please feel free to ask Dr. Alex Jimenez, DC, APRN, FNP-BC, or contact us at 915-850-0900.
We are here to help you and your family.
Blessings
Dr. Alex Jimenez DC, MSACP, APRN, FNP-BC*, CCST, IFMCP, CFMP, ATN
email: coach@elpasofunctionalmedicine.com
Multidisciplinary Licensing & Board Certifications:
Licensed as a Doctor of Chiropractic (DC) in Texas & New Mexico*
Texas DC License #: TX5807, Verified: TX5807
New Mexico DC License #: NM-DC2182, Verified: NM-DC2182
Multi-State Advanced Practice Registered Nurse (APRN*) in Texas & Multi-States
Multi-state Compact APRN License by Endorsement (42 States)
Texas APRN License #: 1191402, Verified: 1191402 *
Florida APRN License #: 11043890, Verified: APRN11043890 *
Colorado License #: C-APN.0105610-C-NP, Verified: C-APN.0105610-C-NP
New York License #: N25929, Verified N25929
License Verification Link: Nursys License Verifier
* Prescriptive Authority Authorized
ANCC FNP-BC: Board Certified Nurse Practitioner*
Compact Status: Multi-State License: Authorized to Practice in 40 States*
Graduate with Honors: ICHS: MSN-FNP (Family Nurse Practitioner Program)
Degree Granted. Master's in Family Practice MSN Diploma (Cum Laude)
Dr. Alex Jimenez, DC, APRN, FNP-BC*, CFMP, IFMCP, ATN, CCST
(Board Certified: Family Practice Nurse Practitioner—Multistate)*
(Licensed Nurse Practitioner & Chiropractor - Multistate)*
Clinical Director
Digital Business Card
Dr. Maria Cardenas, MD
(Board Certified: Internal Medicine)
(Licensed Medical Doctor)
Medical Director, Clinical Director & Collaborative Physician
NPI # 1164426749
MD License #: J2933
Licenses and Board Certifications:
MD: Medical Doctor
DC: Doctor of Chiropractic
APRNP: Advanced Practice Registered Nurse
FNP-BC: Family Practice Specialization (Multi-State Board Certified)
RN: Registered Nurse (Multi-State Compact License)
CFMP: Certified Functional Medicine Provider
MSN-FNP: Master of Science in Family Practice Medicine
MSACP: Master of Science in Advanced Clinical Practice
IFMCP: Institute of Functional Medicine
CCST: Certified Chiropractic Spinal Trauma
ATN: Advanced Translational Neutrogenomics
Memberships & Associations:
TCA: Texas Chiropractic Association: Member ID: 104311
AANP: American Association of Nurse Practitioners: Member ID: 2198960
ANA: American Nurse Association: Member ID: 06458222 (District TX01)
TNA: Texas Nurse Association: Member ID: 06458222
NPI: 1205907805
| Primary Taxonomy | Selected Taxonomy | State | License Number |
|---|---|---|---|
| No | 111N00000X - Chiropractor | NM | DC2182 |
| Yes | 111N00000X - Chiropractor | TX | DC5807 |
| Yes | 363LF0000X - Nurse Practitioner - Family | TX | 1191402 |
| Yes | 363LF0000X - Nurse Practitioner - Family | FL | 11043890 |
| Yes | 363LF0000X - Nurse Practitioner - Family | CO | C-APN.0105610-C-NP |
| Yes | 363LF0000X - Nurse Practitioner - Family | NY | N25929 |
Dr. Alex Jimenez, DC, APRN, FNP-BC*, CFMP, IFMCP, ATN, CCST
(Board Certified: Family Practice Nurse Practitioner—Multistate)*
(Licensed Nurse Practitioner & Chiropractor - Multistate)*
Clinical Director
Digital Business Card
Dr. Maria Cardenas, MD
(Board Certified: Internal Medicine)*
(Licensed Medical Doctor)*
Medical Director, Clinical Director & Collaborative Physician
NPI # 1164426749
MD License #: J2933
Dr Maria Cardenas, MD, Medical License Dr. Maria Cardenas, MD (Board Certified in Internal Medicine)… Read More
How PRP Composition Influences Healing and Recovery Abstract In the evolving field of regenerative medicine,… Read More
by: Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST Read More
Regenerative Medicine for Hip Osteoarthritis: An Integrative Approach to Pain and Function Abstract Hip osteoarthritis… Read More
by Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST Read More
El Paso Motorcycle Brain Injury Recovery After a Helmeted Crash A motorcycle helmet can save… Read More
Personal Injury, Trauma & Spine Rehab. Specialists